1712 Carey Ave. Ste 200 Cheyenne, WY 82002
Phone: 307-634-9636 Fax: 307-634-6335 bop@wyo.gov
Mission Statement
The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.
Current News & Information
The Wyoming State Board of Pharmacy proposes to amend Chapter 1: Rules of Practice and Procedure of the Wyoming Pharmacy Act Rules and Regulations in order to modernize and reorganize the chapter and bring it in closer alignment to the state’s model practice rules for licensing agencies.
As required by Wyoming Statute § 16-3-103(a)(i)(G), these rules meet minimum substantive state statutory requirements.
Chapter 1: Rules of Practice and Procedure
Unnecessary sections are removed and subsequent sections are renumbered as appropriate.
The Board’s Application Review Process is modernized and brought closer to the state’s model practice rules for licensing agencies; providing specific actions that the Board shall take if grounds for denying a license exist; clarifying the remedies available to the applicant.
A new section, Hearing Procedure for License Denials, is created providing required actions that the Board shall take upon the written request for a hearing from an applicant; providing requirements for the applicant; and methods of resolution.
The Board’s requirements for complaints are modernized; removing the requirement that the complaint be notarized; providing that the identity of a complainant may be withheld; providing criteria when the identity of a complainant may be disclosed.
Sections on Summary Suspension, Hearing Format for Summary Suspensions, Post-Deprivation Hearing, Hearing Procedure for Licensees, Petition for Modifying Conditions of Restrictions, and Expungement of Disciplinary Action are created. These sections expound on the actions, responsibilities, and remedies available to the Board when grounds exist to act against a licensee. These sections also provide remedies available to licensees, and requirements to be met when the Board has initiated action against the licensee.
Incorporations by reference are updated and modernized.
Requests for copies of the proposed revisions may be addressed to the Board executive director at 1712 Carey Avenue, Suite 200, Cheyenne, WY 82002. The proposed revisions are posted on the Wyoming Secretary of State and the Wyoming State Board of Pharmacy websites.
Comments may be submitted to the Board by mail using the address above or to bop@wyo.gov on or before June 11, 2024, at 5 PM MDT.
2024-2025 License Renewals Are Open
Business licenses (resident pharmacies, nonresident pharmacies, wholesale distributors, etc.), business-controlled substance registrations, and individual control substance registrant renewals are now open. Click below to learn more and renew your license.
Individual controlled substance registrants (MD, DO, PA, APRN, DDS, DVM, etc.)
Resident pharmacies (resident retail and resident institutional)
Wholesale distributors of prescription drugs for human use, veterinary use, or medical oxygen
Alerts & Other Information
A Reminder that PREP Act Declaration for COVID-19 Countermeasures were extended through December 2024
PREP Act immunity from liability was extended by HHS through December 2024 to pharmacists, pharmacy interns, and pharmacy technicians to administer COVID-19 and seasonal influenza vaccines (to those individuals three and over, consistent with other requirements), and COVID-19 tests, regardless of any USG agreement or emergency declaration.
REMINDER ALERT
Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert
The Board's September 2022 newsletter had an article on the Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition's fraud alert that outlines some new methodologies that are being used to divert both small and large drug shipments. These schemes may involve the impersonation of regulatory personnel, including individuals from state boards of pharmacy and departments of health. They may also involve the impersonation of pharmacy or distributor staff.
Last week a pharmacy in Casper reported being contacted by a scammer posing as the Wyoming Board of Pharmacy, who tried to obtain their wholesale distributor account number. In 2022, a pharmacy in Rock Springs, WY, reported being contacted by a scammer posing as their distributor, who said that they had shipped product to the pharmacy in error and requested that the shipment be returned.
More information is available from the National Association of Boards of Pharmacy®. If you experience an attempt at this type of scam, please email cforsaith@hda.org so that it can be shared with law enforcement.
ALERT Phishing Scam
The Board office has received reports that pharmacists are receiving calls that appear to come from the Board office’s main phone number and that the caller identifies himself or herself as an agent with the Board. The caller is able to confirm some of the pharmacist’s information, such as license number, National Provider Identifier number, and place of employment.
In some cases, the caller accuses the pharmacist of having committed a violation, that his or her license may be suspended or revoked, and that the pharmacist will be arrested if he or she does not answer the caller’s questions. In some cases, the caller alleges that the pharmacist was involved in prescription drug trafficking. Some pharmacists have reported that the caller becomes aggressive and demanding, threatening to have the Federal Bureau of Investigation come and arrest the pharmacist if he or she does not comply.
The Wyoming State Board of Pharmacy will not contact or interact with you in this manner.
The Federal Trade Commission has useful consumer information on how to recognize and avoid phishing scams available at https://www.consumer.ftc.gov/articles/how-recognize-and-avoid-phishing-scams. If you receive such a phone call, please call and report it to the Federal Communications Commission at 888/225- 5322.
ALERT Fraudulent Prescription SCAM
The Board has received alerts from pharmacies that an individual or group of individuals are calling in prescriptions for Azithromycin, Ibuprofen, and Promethazine with Codeine. Most of the calls have allegedly come from practitioners in Washington. In some instances, they are asking for particular manufacturers of Promethazine with Codeine, attempting to call multiple sets of prescriptions in at one time, and have requested the pharmacy to ship into another state. The Board urges pharmacists to be cautious and to utilize their professional judgment when exercising their corresponding responsibility and to carefully evaluate such prescriptions for validity before dispensing.